MacDougall Advisors, Inc., a strategic communications and business advisory firm working with leading public and private healthcare innovation companies around the world, today announced it has been selected by the Boston Business Journal as one of the Best Places to Work in 2022.

“It’s an honor to be recognized as a Best Place to Work alongside such amazing companies in Massachusetts. This is a big testament to our company’s values, culture and the deep sense of teamwork that has led MacDougall to success over the last 20 years,” said Karen Sharma, Managing Partner, MacDougall Advisors. “I am so proud of this team. Each and every person at MacDougall brings collegiality, professionalism, creativity and kindness to the stellar work they do on behalf of our clients and the biotech community.”

Best Places to Work is designed to honor the area’s leading employers. The prestigious award recognizes companies that go beyond the norm to foster an enjoyable and meaningful work environment for their employees. The award evaluates organizations of all sizes based on the following: communication and resources, individual needs, manager effectiveness, personal engagement, team dynamics and trust in leadership.

“We are so glad to be able to celebrate this year’s Best Places to Work in person. These companies signify teamwork, retention, engagement and trust with co-workers and senior leaders. Together they create a dynamic, innovative place where people want to work and grow,” said Carolyn Jones, Market President and Publisher of the Boston Business Journal.

The Boston Business Journal recognized the finalists last week and plans to announce the final rankings at an evening cocktail reception and awards celebration on June 16 at the Boston Park Plaza from 5:30 – 8:30 pm.

About MacDougall Advisors

MacDougall is a team of experienced, multi-talented consultants providing an integrated suite of communications services to organizations creating innovation in biomedicine and healthcare. We are passionate about helping our clients in their quest to improve patients’ lives. For over 20 years, we have successfully fostered the growth of the biotech sector by working with companies and organizations to build credibility, visibility and valuation.